Nermeen Bleedy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nermeen Bleedy has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Hassan Abdelnour
Department of Rehabilitation Sciences. College of Medical Sciences, Northern Border University, Arar, KSA
2 shared publications - Abdelrazak A Ahmed
Physiotherapy Department, Faculty of Applied Medical Sciene, Jerash University, Jerash, Jordan
1 shared publication - Abdul-Majeed Almalty
Department of Physical Therapy, Faculty of Applied Medical Science, The Hashemite University, Zarqa, Jordan
1 shared publication - Ahmed Ibrahim Al Kharusi
School of Rehabilitation and Allied Health Sciences, University of Nizwa, Birkat Al Mouz, Oman
1 shared publication - Baha'A M. Abu Salma
Department of Nutrition and Food Sciences, Faculty of Agriculture, Jerash University, Jerash, Jordan
1 shared publication - Bayan Obeidat
Department of Nutrition and Food Technology Faculty of Agriculture Jordan University of Science and Technology Irbid Jordan just.edu.jo
1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 19, 1-9
Effects of Acetylcholine on Endothelial Function and Nitric Oxide Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Sham-Controlled Study
Background: Peripheral neuropathy is a prevalent neurological disorder with multiple etiologies. Nerve damage frequently occurs due to prolonged high blood sugar levels and diabetes. Peripheral nerve fiber impairment, mediated mainly through dysregulation of Nitric Oxide Synthase (NOS) activity, induces irreversible structural damage. Acetylcholine induces vasodilation by stimulating endothelial nitric oxide (NO) production, which relaxes smooth muscle, and by triggering a nerve axon reflex. This reflex releases neuropeptides like substance P, which further dilate vessels and prompt histamine release. This study aims to evaluate the effects of Acetylcholine (Ach) iontophoresis as a vasodilator on endothelial NOS activity to develop a non-invasive transdermal treatment that is effective and devoid of systemic adverse side effects. Methods: Eighty patients, both male and female, diagnosed with type 2 Diabetes Mellitus were randomly assigned to two groups. The experimental group (A) underwent iontophoresis using acetylcholine for 15 min three times a week for four weeks. The control group (B) underwent 15-minute sessions of sham iontophoresis three times a week for four weeks. Nitric oxide levels and nerve conduction studies of peripheral nerves were assessed pre and post-treatment for both groups. Results: The study demonstrated a statistically significant improvement in endothelium-dependent vasodilation and Nitric Oxide (NO) levels in Group A compared to Group B. However, no significant differences were observed between the groups in terms of electrophysiological outcomes for peripheral nerves and muscles, both pre- and post-treatment. Conclusion: Repeated acetylcholine iontophoresis significantly improved microvascular function, increasing nitric oxide release and tissue perfusion in patients with diabetic neuropathy. While no immediate changes in peripheral nerve conduction were observed, the intervention shows promise as an adjunctive strategy for supporting microvascular health in diabetic neuropathic complications.
- 1 September 2026
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 19, 1-9
Open AccessEffects of Acetylcholine on Endothelial Function and Nitric Oxide Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Sham-Controlled Study
Background: Peripheral neuropathy is a prevalent neurological disorder with multiple etiologies. Nerve damage frequently occurs due to prolonged high blood sugar levels and diabetes. Peripheral nerve fiber impairment, mediated mainly through dysregulation of Nitric Oxide Synthase (NOS) activity, induces irreversible structural damage. Acetylcholine induces vasodilation by stimulating endothelial nitric oxide (NO) production, which relaxes smooth muscle, and by triggering a nerve axon reflex. This reflex releases neuropeptides like substance P, which further dilate vessels and prompt histamine release. This study aims to evaluate the effects of Acetylcholine (Ach) iontophoresis as a vasodilator on endothelial NOS activity to develop a non-invasive transdermal treatment that is effective and devoid of systemic adverse side effects. Methods: Eighty patients, both male and female, diagnosed with type 2 Diabetes Mellitus were randomly assigned to two groups. The experimental group (A) underwent iontophoresis using acetylcholine for 15 min three times a week for four weeks. The control group (B) underwent 15-minute sessions of sham iontophoresis three times a week for four weeks. Nitric oxide levels and nerve conduction studies of peripheral nerves were assessed pre and post-treatment for both groups. Results: The study demonstrated a statistically significant improvement in endothelium-dependent vasodilation and Nitric Oxide (NO) levels in Group A compared to Group B. However, no significant differences were observed between the groups in terms of electrophysiological outcomes for peripheral nerves and muscles, both pre- and post-treatment. Conclusion: Repeated acetylcholine iontophoresis significantly improved microvascular function, increasing nitric oxide release and tissue perfusion in patients with diabetic neuropathy. While no immediate changes in peripheral nerve conduction were observed, the intervention shows promise as an adjunctive strategy for supporting microvascular health in diabetic neuropathic complications.
- Open Access
- 12 June 2026
- Published by Springer Nature in Discover Psychology
- Vol. 6 (1)
Exploring sensory changes and social withdrawal among stroke survivors: a qualitative study
- 12 June 2026
- Published by Springer Nature in Discover Psychology
- Vol. 6 (1)
Open AccessExploring sensory changes and social withdrawal among stroke survivors: a qualitative study
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2026 (1)
Central Obesity and Estimated Coronary Heart Disease Risk Among Jordanian Women Aged 30–50 Years: A Framingham Risk Score Analysis
Background: Obesity is a well‐established modifiable risk factor for cardiovascular disease (CVD), particularly coronary heart disease (CHD). Its high prevalence among Jordanian women aged 30–50 years highlights the need for early cardiovascular risk assessment to support targeted preventive strategies. Objective: To estimate the 10‐year risk of CHD among Jordanian women aged 30–50 years using the Framingham risk score (FRS) and to examine the associations between general obesity, central obesity, cardiometabolic risk factors, and estimated CHD risk. Methods: A cross‐sectional study was conducted among 230 Jordanian women aged 30–50 years who were recruited using a multistage cluster sampling technique. Standardized anthropometric measurements, including body weight, height, and waist circumference (WC), were obtained to calculate body mass index (BMI) and waist‐to‐height ratio (WHtR). Blood pressure was measured according to standardized procedures, and fasting blood samples were analyzed to determine fasting blood glucose and lipid profile parameters. Smoking status and physical activity were assessed using structured questionnaires. The 10‐year risk of CHD was estimated using the FRS. Descriptive and inferential statistical analyses were performed to evaluate the associations between obesity indices and estimated CHD risk. Results: General obesity was identified in 39.1% of participants, while 40.9% had central obesity based on WC (≥ 88 cm). Nearly half of the participants (47.0%) were current smokers, and 21.3% reported low levels of physical activity. According to the FRS, 66.1% of participants were classified as having low CHD risk, 16.5% as moderate risk, and 17.4% as high risk. Higher BMI and central obesity were significantly associated with elevated blood pressure, fasting blood glucose, triglyceride levels, and LDL cholesterol, as well as lower HDL cholesterol (all p < 0.001). Smoking, physical inactivity, and both general and central obesity were significantly associated with an increased estimated risk of CHD. Conclusion: Jordanian women aged 30–50 years exhibited a substantial burden of both general and central obesity, accompanied by an increased estimated risk of CHD. These findings underscore the importance of routine cardiovascular risk assessment and comprehensive lifestyle interventions focusing on weight management, smoking cessation, and regular physical activity. Because the FRS has not been specifically validated in Jordanian women, the estimated absolute cardiovascular risk should be interpreted with caution.
- 1 January 2026
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2026 (1)
Open AccessCentral Obesity and Estimated Coronary Heart Disease Risk Among Jordanian Women Aged 30–50 Years: A Framingham Risk Score Analysis
Background: Obesity is a well‐established modifiable risk factor for cardiovascular disease (CVD), particularly coronary heart disease (CHD). Its high prevalence among Jordanian women aged 30–50 years highlights the need for early cardiovascular risk assessment to support targeted preventive strategies. Objective: To estimate the 10‐year risk of CHD among Jordanian women aged 30–50 years using the Framingham risk score (FRS) and to examine the associations between general obesity, central obesity, cardiometabolic risk factors, and estimated CHD risk. Methods: A cross‐sectional study was conducted among 230 Jordanian women aged 30–50 years who were recruited using a multistage cluster sampling technique. Standardized anthropometric measurements, including body weight, height, and waist circumference (WC), were obtained to calculate body mass index (BMI) and waist‐to‐height ratio (WHtR). Blood pressure was measured according to standardized procedures, and fasting blood samples were analyzed to determine fasting blood glucose and lipid profile parameters. Smoking status and physical activity were assessed using structured questionnaires. The 10‐year risk of CHD was estimated using the FRS. Descriptive and inferential statistical analyses were performed to evaluate the associations between obesity indices and estimated CHD risk. Results: General obesity was identified in 39.1% of participants, while 40.9% had central obesity based on WC (≥ 88 cm). Nearly half of the participants (47.0%) were current smokers, and 21.3% reported low levels of physical activity. According to the FRS, 66.1% of participants were classified as having low CHD risk, 16.5% as moderate risk, and 17.4% as high risk. Higher BMI and central obesity were significantly associated with elevated blood pressure, fasting blood glucose, triglyceride levels, and LDL cholesterol, as well as lower HDL cholesterol (all p < 0.001). Smoking, physical inactivity, and both general and central obesity were significantly associated with an increased estimated risk of CHD. Conclusion: Jordanian women aged 30–50 years exhibited a substantial burden of both general and central obesity, accompanied by an increased estimated risk of CHD. These findings underscore the importance of routine cardiovascular risk assessment and comprehensive lifestyle interventions focusing on weight management, smoking cessation, and regular physical activity. Because the FRS has not been specifically validated in Jordanian women, the estimated absolute cardiovascular risk should be interpreted with caution.